L. Soussan et al., ANTIBODIES TO DIFFERENT ISOFORMS OF THE HEAVY NEUROFILAMENT PROTEIN (NF-H) IN NORMAL AGING AND ALZHEIMERS-DISEASE, Molecular neurobiology, 9(1-3), 1994, pp. 83-91
Sera of normal controls and of patients with neurological diseases con
tain antineurofilament antibodies. Recent studies suggest that biochem
ically and immunologically distinct subclasses of neurofilaments occur
in different types of neurons. Alzheimer's disease (AD), the major ca
use of dementia, is associated with a marked degeneration of brain cho
linergic neurons. In the present work we characterized the repertoire
and age dependence of antineurofilament antibodies in normal sera and
examined whether the degeneration of cholinergic neurons in AD is asso
ciated with serum antibodies directed specifically against the neurofi
laments of mammalian cholinergic neurons. This was performed by immuno
blot assays utilizing neurofilaments from the purely cholinergic bovin
e ventral root neurons and from the chemically heterogeneous bovine do
rsal root neurons, Antibodies to the heavy neurofilament protein NF-H
were detected in normal control sera. Their levels were significantly
higher in older (aged 70-79) than in younger (aged 40-59) subjects. Th
ese antibodies bound similarly to bovine ventral root and dorsal root
NF-H and their NF-H specificity was unchanged during aging. In contras
t, the levels of IgG in AD sera that are directed against ventral root
cholinergic NF-H were higher than those directed against the chemical
ly heterogeneous dorsal root NF-H. Immunoblot experiments utilizing de
phosphorylated ventral root and dorsal root NF-H and chymotryptic frag
ments of these molecules revealed that AD sera contain a repertoire of
antimamalian NF-H IgG. A subpopulation of these antibodies binds to p
hosphorylated epitopes that are specifically enriched in ventral root
cholinergic NF-H and that are located on the carboxy terminal domain o
f this molecule. The level of these anticholinergic NF-H IgG are signi
ficantly higher in AD sera than in those of both normal controls and p
atients with multi-infarct dementia.